Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany

Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany

Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG has been introduced to optimize ATG dosing, substa...

Full description

Bibliographic Details
Main Authors: Lisa V.E. Oostenbrink, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Emma S. Pool, Astrid G.S. van Halteren, Dirk Jan A.R. Moes, Robbert G.M. Bredius, Alex B. Mohseny, Frans J.W. Smiers, Maarten J.D. van Tol, Marco W. Schilham, Arjan C. Lankester
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Hematology/Oncology and Stem Cell Therapy
Subjects:
ATG
Grafalon
Thymoglobulin
Haploidentical HSCT
Pediatrics
Sickle cell disease
Online Access:http://www.sciencedirect.com/science/article/pii/S1658387620300182

Internet

http://www.sciencedirect.com/science/article/pii/S1658387620300182

Similar Items